| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.20B | +16.3% |
| Cost of Revenue | $782.0M | +11.8% |
| Gross Profit | $2.41B | +17.9% |
| R&D Expense | $767.4M | +10.7% |
| SG&A Expense | $300.7M | +13.2% |
| Operating Income | $916.4M | +32.5% |
| Pre-tax Income | $1.19B | +29.9% |
| Income Tax | $285.6M | +39.2% |
| Net Income | $908.9M | +27.3% |
| EPS (Basic) | $5.55 | +25.9% |
| EPS (Diluted) | $5.44 | +25.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | +27.0% |
| Accounts Receivable | $1.26B | +23.9% |
| Current Assets | $8.00B | +26.8% |
| Total Assets | $8.98B | +22.3% |
| Current Liabilities | $1.64B | +17.1% |
| Total Liabilities | $1.76B | +17.1% |
| Stockholders' Equity | $7.21B | +23.7% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.42B | +29.8% |
| Investing Cash Flow | -$1.10B | -57.7% |
| Financing Cash Flow | -$9.3M | -135.7% |